TABLE 1.
Characteristic | Patients |
P valueb | ||
---|---|---|---|---|
All (n = 63) | ARV naive (n = 18) | ARV treated (n = 45) | ||
Women (n [%]) | 39 (62) | 14 (78) | 25 (56) | 0.15 |
Age (years) (median [IQR]) | 50 (43–55) | 46 (42–52) | 51 (43–58) | 0.09 |
CD4 cell count (cells/mm3) (median [IQR]) | 485 (280–599) | 603 (454–706) | 424 (190–550) | 0.003 |
HIV-2 RNA load detected | ||||
Below the limit of quantification (n [%]) | 28 (44) | 6 (33) | 22 (49) | 0.4 |
In patients with quantifiable viremia (log10 copies/ml) (median [IQR]) | 2.62 (2.16–3.64) | 2.22 (1.96–2.65) | 3.15 (2.48–3.88) | 0.01 |
HIV-2 DNA load detected | ||||
Below the limit of quantification (n [%]) | 20 (32) | 8 (44) | 12 (27) | 0.23 |
In patients with quantifiable HIV-2 DNA (log10 copies/106 PBMCs) (median [IQR]) | 2.45 (2.15–3.00) | 2.08 (1.88–2.28) | 2.60 (2.26–3.09) | 0.003 |
ARV, antiretroviral; IQR, interquartile range; PBMC, peripheral blood mononuclear cell.
Significant P values are in boldface font.